Novel Non-Invasive PET Imaging of Reactive Oxygen Species Using [18 F]ROStrace in Three Proteinopathy-Associated Neurodegenerative Mouse Models.

RATIONALE AND

OBJECTIVES

Prolonged oxidative stress, driven by aggregation of misfolded proteins such as amyloid beta (Aβ), alpha-synuclein (aSyn), and tau, plays a key role in neurodegenerative disease (ND) progression. Yet, the lack of noninvasive tools to monitor oxidative stress in vivo limits clinical tracking of disease. To address this, we evaluated [18 F]ROStrace, a novel superoxide (O₂·⁻)-sensitive PET tracer, in three proteinopathy-associated ND mouse models.

MATERIALS AND

METHODS

To validate [18 F]ROStrace's reactive oxygen species (ROS)-detecting ability across different types of NDs, we used three proteinopathy-associated ND mouse models: APP/PS1 (Alzheimer's disease, [AD]), A53T (Parkinson's disease, [PD]), and PS19 (4R tauopathy, [AD]). Each group of mice received [18 F]ROStrace injections at various ages, followed by 60 min dynamic micro-PET scans. Brain tissues were collected 24 h later for immunofluorescence to correlate tracer retention with proteinopathy-induced oxidative damage.

RESULTS

[18 F]ROStrace is highly sensitive in detecting increased oxidative stress in all three ND animal models. Furthermore, region-specific elevations in [18 F]ROStrace retention strongly correlated with the abnormal aggregation of misfolded proteins and oxidative damage, highlighting the tracer's ability to pinpoint affected brain areas in different neurodegenerative conditions.

CONCLUSIONS

By enabling early identification of oxidative stress, [18 F]ROStrace holds significant potential for improving ND diagnosis, monitoring disease trajectory, and evaluating therapeutic interventions targeting oxidative damage.